ADAM33: a newly identified protease involved in airway remodelling

Holgate, S.T., Davies, D.E., Powell, R.M. and Holloway, J.W. (2006) ADAM33: a newly identified protease involved in airway remodelling. Pulmonary Pharmacology & Therapeutics, 19 (1), 3-11. (doi:10.1016/j.pupt.2005.02.008).

Abstract

Asthma is a complex disorder in which major genetic and environmental factors interact to both initiate the disease and modify its progression. While asthma is recognised as a disorder of the conducting airways characterised by Th2-directed inflammation, it is being increasingly apparent that alteration of the structural cells of the airways (airway remodelling) is also fundamental to disease chronicity and severity. The gene ADAM33, encoding a novel member of a identified as an asthma susceptibility gene as the result of a positional cloning effort in a cohort of families recruited form the UK and USA. Subsequent genetic studies have now provided evidence that ADAM33 may be involved in determining lung function throughout life, associated with early life lung function as well as increased decline therapeutic intervention in asthma and future work will focus on the mechanisms by which it alters lung function and bronchial hyperresponsiveness.

This record has no associated files available for download.

Contributors

Author: D.E. Davies

Author: J.W. Holloway

Download statistics